Skip to main content
SpringerLink
Log in

The Role of Hepatitis C Virus in Hepatocellular Carcinoma

  • Conference paper
Genes and Environment in Cancer

Part of the book series: Recent Results in Cancer Research ((RECENTCANCER,volume 154))

Abstract

The sequential development of cirrhosis and hepatocellular carcinoma (HCC) in patients with post-transfusion hepatitis was a clue that led to the identification of hepatitis C virus (HCV) as a risk factor for HCC. The average time lag between transfusion-associated infection and cancer development was 30 years, with a range of 15–45 years. Using the polymerase chain reaction (PCR) technique, HCV-RNA has been almost invariably detected in serum and tumor tissue of anti-HCV-seropositive patients with HCC In many patients, HCV-RNA was found to belong to the more pathogenic type lb. However, it is unlikely that HCV plays a direct role in liver tumorigenesis, since no reverse transcriptase activity has been found in infected livers. One current opinion is that HCV may promote cancer through cirrhosis, which is per se an important risk factor for this tumor: almost all patients with HCC have cirrhosis and up to 30% of them have coexisting serological evidence of hepatitis B virus (HBV) or alcohol abuse, further supporting the idea that both HCC and cirrhosis might result from the interplay of several risk factors. However, there are also data suggesting that HCV may interact with cellular genes regulating cell growth and differentiation independently of the onset of cirrhosis.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Ayoola EA, Odelola HA, Johnson AOK (1982) Primary liver cancer (PLC) after non-A, non-B hepatitis (NANBH) Hepatology 2: 154

    Google Scholar 

  • Bosch FX, Munoz N (1991) Hepatocellular carcinoma in the world: epidemiologic questions. In: Tabor E, Di Bisceglie AM, Purcell RH (eds) Etiology, pathology and treatment of hepatocellular carcinoma in North America. Gulf, Houston, pp 35–54

    Google Scholar 

  • Bottelli R, Mondazzi L, Asti L, Rezakovic I, Bellati G, Marotta F, Ideo G (1991) Confronting different methods in determination of anti-HCV antibodies in chronic liver disease. 3rd International Symposium on HCV, Strasbourg, Sept 16–17

    Google Scholar 

  • Bruix J, Barrera JM, Calvet X, Costa J, Ventura M, Bruguera M, Castillo R, Ercilla G, Sanchez-Tapias JM, Vall M, Bru C, Rodes J (1989) Prevalence of antibodies to hepatitis C virus in Spanish patients with hepatocellular carcinoma and hepatic cirrhosis. Lancet 2: 1004–1006

    Article  PubMed  CAS  Google Scholar 

  • Bruno S, Sîlini E, Crosignani A, Bonino F, Leandro G, Bono F, Asti M, Rossi S, Larghi A, Cerino A, Podda M, Mondelli MU (1997) Hepatitis C virus genotypes and risk of hepatocellular carcinoma in cirrhosis: a prospective study. Hepatology 25: 754–758

    Article  PubMed  CAS  Google Scholar 

  • Chen DS, Kuo GC, Sung JL, Lai MY, Sheu HC, Chen PJ, Yang PM, Hsu HM, Chang MH, Chen CJ, Hahn LC, Choo QL, Wang TH, Houghton M (1991) Hepatitis C virus infection in an area hyperedemic for hepatitis B and chronic liver disease: the Taiwan experience. J Infect Dis 162: 817–822

    Article  Google Scholar 

  • Chiaramonte M, Farinati F, Fagiuoli S, Ongaro S, Aneloni V, De Maria N, Naccarato R (1990) Antibody to hepatitis C virus in hepatocellular carcinoma. Lancet 1: 300–302

    Google Scholar 

  • Chuang WL, Chang WY, Lu SN, Su WP, Lin ZY, Chen SC, Hsieh MY, Wang LY, You SL, Chen SJ (1992) The role of hepatitis B and C in hepatocellular carcinoma in a hepatitis B endemic area. Cancer 69: 2052–2054

    Article  PubMed  CAS  Google Scholar 

  • Cohen EB, Gang DL, Zeldis JB (1987) Primary hepatocellular carcinoma following non specific non-B hepatitis with tumor DNA negative for HBV-DNA. Dig Dis Sci 32: 1428–1430

    Article  PubMed  CAS  Google Scholar 

  • Colombo M, Kuo G, Choo QL, Donato MF, Del Ninno E, Tommasini MA, Dioguardi N, Houghton M (1989) Prevalence of antibodies to hepatitis C virus in Italian patients with hepatocellular carcinoma. Lancet 2: 1006–1008

    Article  PubMed  CAS  Google Scholar 

  • Colombo M, Mannucci PM, Brettler DB, Girolami A, Lian ECY, Rodeghiero F, Scharrer I, Smith PS, White GC II (1991) Hepatocellular carcinoma in hemophilia. Am J Hematol 37: 243–246

    Article  PubMed  CAS  Google Scholar 

  • Dazza MC, Meneses LV, Girard PM, Villaroel C, Brechot C, Larouze B (1990) Hepatitis C antibody and hepatocellular carcinoma. Lancet 1: 1216

    Google Scholar 

  • Ducreux M, Buffet C, Dussaix EA, Pelletier G, Briantais MJ, Yvart Y, Jaques L, Etienne JP (1990) Antibody to hepatitis C virus in hepatocellular carcinoma. Lancet 1: 301

    Google Scholar 

  • Gerber MA, Shieh YS, Shim KS, Thung SN, Demetris AJ, Schwartz M, Akyol G, Dash S (1992) Detection of replicative hepatitis C virus sequences in hepatocellular carcinoma. Am J Pathol 144: 1271–1277

    Google Scholar 

  • Gilliam JH, Geisinger KR, Richter JE (1984) Primary hepatocellular carcinoma after choronic non-A, non-B post-transfusion hepatitis. Ann Intern Med 101: 794–795

    PubMed  Google Scholar 

  • Guadagnino V, Stroffolini T, Rapicetta M, Costantino A, Kondili LA, Menniti-Ippolito F, Caroleo B, Costa C, Griffo G, Loiacono L, Pisani V, Foch A, Piazza M (1997) Prevalence, risk factors, and genotype distribution of hepatitis C virus infection in the general population: a community-based survey in Southern Italy. Hepatology 26: 1006–1011

    Article  PubMed  CAS  Google Scholar 

  • Hasan F, Jeffers LJ, De Medina M, Rajender Reddy K, Parker T, Schiff ER, Houghton M, Choo QL, Kuo G (1990) Hepatitis C-associated hepatocellular carcinoma. Hepatology 12: 589–591

    Article  PubMed  CAS  Google Scholar 

  • Kaklamani E, Trichopoulos D, Tzonou A, Zavitsanos X, Koumantaki Y, Hatzakis A, Hsieh CC, Hadziyannis S (1991) Hepatitis B and C viruses and their interaction in the origin of hepatocellular carcinoma. Jama 265: 1974–1976

    Article  PubMed  CAS  Google Scholar 

  • Kew MC, Houghton M, Choo QL, Kuo GA (1990) Hepatitis C virus antibodies in Southern African blacks with hepatocellular carcinoma. Lancet 1: 873–874

    Article  Google Scholar 

  • Kiyosawa K, Akahana Y, Nagata A, Furuta S (1984) Hepatocellular carcinoma after non-A, non-B post-transfusion hepatitis. Am J Gastroenterol 79: 777–781

    PubMed  CAS  Google Scholar 

  • Kiyosawa K, Sodeyama T, Tanaka E, Gibo Y, Yoshizawa K, Nakano Y, Furuta S, Akahane Y, Nishioka K, Purcell RH, Alter HJ (1990) Interrelationship of blood transfusion, non-A, non-B hepatitis and hepatocellular carcinoma: analysis by detection of antibody to hepatitis C virus. Hepatology 12: 671–675

    Article  PubMed  CAS  Google Scholar 

  • Levrero M, Tagger A, Balsano C, De Marzio E, Avantaggiati ML, Natoli G, Diop D, Villa E, Diodati G, Alberti A (1991) Antibodies to hepatitis C virus in patients with hepatocellular carcinoma. J Hepatol 12: 60–63

    Article  PubMed  CAS  Google Scholar 

  • Martelli C, Massaro C, Zulian M, Blandamura S (1991) Sulla frequenza del carcinoma epatico primitivo nel settorato di Venezia dal 1906 al 1988. Pathologica 83: 249–258

    PubMed  CAS  Google Scholar 

  • Nalpas B, Driss F, Pol S, Hamelin B, Housset C, Brechot C, Berthelot P (1991) Association between HCV and HBV infection in hepatocellular carcinoma and alcoholic liver disease. J Hepatol 1: 70–74

    Article  Google Scholar 

  • Nishioka K, Watanabe J, Furuta S, Tanaka E, Iino S, Suzuki H, Tsuji T, Yano M, Kuo G, Choo QL, Houghton M, Oda T (1991) A high prevalence of antibody to the hepatitis C virus in patients with hepatocellular carcinoma in Japan. Cancer 67: 429–433

    Article  PubMed  CAS  Google Scholar 

  • Nousbaum JB, Pol S, Nalpas B, Landais P, Berthelot P, Brechot C, the Collaborative Study Group (1995) Hepatitis C virus type lb ( II) infection in France and Italy. Ann Intern Med 122: 161–168

    PubMed  CAS  Google Scholar 

  • Ohkoshi S, Kato N, Kinoshita T, Hijikata M, Ohtsuyama Y, Okazaki N, Ohkura H, Hiroashi S, Honma A, Ozaki T, Yoshikawa A, Kajama H, Asakura H, Shimotohno K (1990) Detection of hepatitis C virus RNA in sera and liver tissues of non-A, non-B hepatitis patients using the polymerase chain reaction. Jpn J Cancer Res 81: 862–865

    Article  PubMed  CAS  Google Scholar 

  • Okuda K (1997) Hepatitis C virus and hepatocellular carcinoma. In: Okuda K (ed) Liver cancer. Churchill Livingstone, New York, pp 39–49

    Google Scholar 

  • Poynard T, Aubert A, Lazizi Y, Bedossa P, Hamelin B, Terris B, Naveau S, Dubreuil P, Pillot J, Chaput JC (1991) Independent risk factors for hepatocellular carcinoma in French drinkers. Hepatology 13: 896–901

    Article  PubMed  CAS  Google Scholar 

  • Ray RB, Steele R, Meyer K, Ray R (1997) Transcriptional repression of p53 promoter by hepatitis C virus core protein. J Biol Chem 272: 10983–10986

    Article  PubMed  CAS  Google Scholar 

  • Resnick RH, Stone K, Antonioli D (1983) Primary hepatocellular carcinoma following non-A, non-B post-transfusion hepatitis. Dig Dis Sci 28: 908–911

    Article  PubMed  CAS  Google Scholar 

  • Ruiz J, Cuende JI, Sangro B, Herrero JI, Beloqui O, Prieto J (1991) Hepatitis C virus (HCV) viremia in patients with hepatocellular carcinoma ( HCC) detected by nested PCR. J Hepatol 413: S165.

    Article  Google Scholar 

  • Ruster B, Zeuzem S, Roth WK (1996) Hepatitis C virus sequences encoding truncated core proteins detected in a hepatocellular carcinoma. Biochem Biophys Res Commun 219: 911–915

    Article  PubMed  CAS  Google Scholar 

  • Saito I, Miyamura T, Ohbayashi A, Harada H, Katayama T, Kikuchi S, Watanabe Y, Koi S, Onji M, Ohta Y, Choo QL, Houghton M, Kuo G (1990) Hepatitis C virus infection is associated with the development of hepatocellular carcinoma. Proc Natl Acad Sci USA 87: 6547–6549

    Article  PubMed  CAS  Google Scholar 

  • Santantanio T, Monno L, Milella M, Fico C, Pastore G (1990) HCV infection in liver cirrhosis and hepatocarcinoma in South Italy. International Symposium on Viral Hepatitis and Liver Disease, Contemporary Issues and Future Prospects, April 4–8, Houston, Texas

    Google Scholar 

  • Sbolli G, Zanetti AR, Tanzi E, Cavanna L, Civardi G, Fornari F, Di Stasi M, Buscarini L (1990) Serum antibodies to hepatitis C virus in Italian patients with hepatocellular carcinoma. J Med Virol 30: 230–232

    Article  PubMed  CAS  Google Scholar 

  • Shibata M, Takeda S, Kudo T, Kimura H, Kuzushita K, Moroshima T, Nagai Y (1991) Minus strand RNA of hepatitis C virus in liver tissues. J Hepatol 13: 379–380

    Article  PubMed  CAS  Google Scholar 

  • Silini E, Bono F, Cividini A, Cerino A, Maccabruni A, Tinelli C, Bruno S, Bellobuono A, Mondelli MU (1995) Molecular epidemiology of hepatitis C virus infection among intravenous drug users. J Hepatol 22: 691–695

    Article  PubMed  CAS  Google Scholar 

  • Simonetti RG, Cottone M, Craxì A, Pagliaro L, Rapicetta M, Chionne P, Costantino A (1989) Prevalence of antibodies to hepatitis C virus in hepatocellular carcinoma. Lancet 2: 1338

    Article  PubMed  CAS  Google Scholar 

  • Srivantanakul P, Parkin DM, Khlat M, Chenvidhya D, Chotiwan P, Insiripong S, L’Abbe KA, Wild CP (1991) Liver cancer in Thailand. II. A case control study of hepatocellular carcinoma. Int J Cancer 48: 329–332

    Article  Google Scholar 

  • Takegami T, Sakamuro D, Peng XX, Hasumura Y, Furukawa T (1995) Hepatitis C virus genome segment encoding NS3 transforms NIH 3T3 mouse cells. 5th International Symposium on Hepatitis C Virus and Related Viruses. 24 Aug - 3 Sept, Brisbane

    Google Scholar 

  • Tang L, Tanaka Y, Enomoto N, Marumo F, Sato C (1995) Detection of hepatitis C virus RNA in hepatocellular carcinoma by in situ hybridization. Cancer 76: 2211–2216

    Article  PubMed  CAS  Google Scholar 

  • Tradati F, Colombo M, Mannucci PM, Rumi MG, De Fazio C, Gamba C, Ciavarella N, Rocino A, Morfini M, Scaraggi A, Taioli E, The Study Group of the Association of Italian Hemophilia Centers (1998) A prospective multicenter study of hepatocellular carcinoma in Italian hemophiliacs with chronic hepatitis C. Blood 91: 1173–1177

    CAS  Google Scholar 

  • Tremolada F, Benvegnu L, Casarin C, Pontisso P, Tagger A, Alberti A (1990) Antibody to hepatitis C virus in hepatocellular carcinoma. Lancet 1: 300–301

    Article  Google Scholar 

  • Vargas V, Castells L, Esteban JI (1990) High frequency of antibodies to hepatitis C virus among patients with hepatocellular carcinoma. Ann Intern Med 112: 232–233

    PubMed  CAS  Google Scholar 

  • Velosa M, Marinho R, Sariva A, Ramalho F, Carneiro de Moura M (1990) Prevalence of anti HCV antibodies in patients with chronic hepatitis and hepatocellular carcinoma. International Symposium on Viral Hepatitis and Liver Disease, Contemporary Issue and Future Aspects, April 4–8, Houston, Texas

    Google Scholar 

  • Watanabe Y, Harada S, Saito I, Miyamura T (1991) Prevalence of antibody against the core protein of hepatitis C virus in patients with hepatocellular carcinoma. Int J Cancer 48: 340–343

    Article  PubMed  CAS  Google Scholar 

  • Yu MC, Tong MJ, Coursaget P, Ross RK, Govindarajan S, Henderson BE (1990) Prevalence of hepatitis B and C viral markers in black and white patients with hepatocellular carcinoma in the United States. J Natl Cancer Inst 82: 1038–1041

    Article  PubMed  CAS  Google Scholar 

  • Zala G, Mevelka J, Joller-Jemelka HJ, Garson JA, Risti B, Meier B, Schmid M, Buhler H (1991) Hepatitis C virus (HCV) and hepatocellular carcinoma (HCC) J Hepatol 13: 5183

    Google Scholar 

  • Zarski JP, Lunel P, Dardelet D, Thelu MA, Baccard M, Perrin M, Huraux JM, Seigneurin JM (1991) Hepatitis C virus and hepatocellular carcinoma in France: detection of antibodies using two second generation assays. J Hepatol 13: 376–377

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. “Angela Maria e Antonio Migliavacca” Center for Liver Disease and the FIRC University Unit for Liver Cancer, IRCCS Maggiore Hospital, University of Milan, Italy

    M. Colombo

Authors
  1. M. Colombo
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Abteilung Zytogenetik, Deutsches Krebsforschungszentrum, Im Neuenheimer Feld 280, D-69120, Heidelberg, Germany

    Manfred Schwab

  2. Pathologisches Institut, Universität München, Thalkirchner Straße 36, D-80377, München, Germany

    Hartmut M. Rabes

  3. Deutsches Krebsforschungszentrum, Im Neuenheimer Feld 280, D-69120, Heidelberg, Germany

    Klaus Munk

  4. Max-Planck-Institut für Biochemie, Am Klopferspitz 18a, D-82152, Martinsried, Germany

    Hans Peter Hofschneider

Rights and permissions

Reprints and permissions

Copyright information

© 1998 Springer-Verlag Berlin · Heidelberg

About this paper

Cite this paper

Colombo, M. (1998). The Role of Hepatitis C Virus in Hepatocellular Carcinoma. In: Schwab, M., Rabes, H.M., Munk, K., Hofschneider, H.P. (eds) Genes and Environment in Cancer. Recent Results in Cancer Research, vol 154. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-46870-4_25

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-46870-4_25

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-46872-8

  • Online ISBN: 978-3-642-46870-4

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation